NCT06206564 - Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 12, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Anal High-grade Squamous Intraepithelial LesionAnal HSILAnal HPV InfectionAIN

Interventions

DRUG

Artesunate ointment

Four 5-day cycles of artesunate ointment given at weeks 0, 2, 4, 6

DRUG

Placebo

Four 5-day cycles of placebo ointment given at weeks 0, 2, 4, 6

Trial Locations (2)

RECRUITING

Laser Surgery Care, New York

RECRUITING

Anal Dysplasia Clinic MidWest, Chicago